An interactive education event curated to bring colleagues from across Greater Manchester together to network, share best practice and hear about the ongoing developments via the Urology Pathway Board.
Suitable for: all healthcare professionals involved in Urology cancer care across Greater Manchester.
We are grateful to the following companies for supporting this event. These companies will be exhibiting at the event, but have had no input into the agenda or content of the day.
We are Merck: As a vibrant science and technology company, we believe in science as a force for good. Founded in1668. We are unique. We have been developing further since 1668. Our ideals have been shaped by our history of more than 350 years. Every generation of the Merck family has contributed in its own way, making us: a leading science and technology company. We are determined to create a world where more cancer patients can become cancer survivors.
Ipsen UK and Ireland: Ipsen U.K. and Ireland is a core part of Ipsen’s global biopharmaceutical business and is driven by the belief that patients don’t have time to wait.
Our licensed medicines and R&D are all focused on improving quality of life and relieving suffering, hoping to bring real value to the healthcare community along every step of the treatment pathway. We push ourselves to address the most complex and difficult issues facing people’s health to deliver better outcomes. This purpose driven approach ensures we deliver real impact, in a sustainable way, for patients and society.
Ipsen works across a diverse oncology portfolio in the U.K. and Ireland, which includes prostate cancer, neuroendocrine tumours, renal cell carcinoma, hepatocellular carcinoma and thyroid cancer.
